Post by Merck Healthcare

Hybrid Drugs—the combination of drug treatment and digital innovation—represent the future of integrative, patient-centered care. Emre Ozcan, PhD, Global Head of Digital Health & Devices recently connected with Dr. Michal Tsur, co-founder and co-CEO of Remepy, a company that’s pioneering a new category of therapy by combining pharmaceuticals with targeted digital interventions, to discuss the collaboration between our companies and how we’re working together to address the full spectrum of patient needs in multiple therapeutic areas. #DigitalTherapeutics #HybridDrugs #AsOneForPatients

Video Content